
Our mission is to facilitate the translation of cancer and CNS disease interventions with improved predictability of clinical outcomes. We do this by offering in vitro and some in vivo assays to characterize and better understand drug products. In-lab services include both traditional 2D and spheroid 3D cell culture using customized cancer cell lines, neurons, or glial cells. Core assays include: drug efficacy, ICC, tumor penetration, and live/dead cell counts by flow cytometry. Neuroinflammation and neural co-culture models are under development. Let’s work together to protect patients from…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$1M to $5M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.